Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18691
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDueymes, M.en
dc.contributor.authorBarrier, J.en
dc.contributor.authorBesancenot, J. F.en
dc.contributor.authorCledes, J.en
dc.contributor.authorConri, C.en
dc.contributor.authorDien, G.en
dc.contributor.authorDrosos, A. A.en
dc.contributor.authorDueymes, J. M.en
dc.contributor.authorGalanaud, P.en
dc.contributor.authorGrobois, B.en
dc.contributor.authoret al.,en
dc.date.accessioned2015-11-24T18:54:30Z-
dc.date.available2015-11-24T18:54:30Z-
dc.identifier.issn1018-2438-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18691-
dc.rightsDefault Licence-
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectAntibodies, Antinuclear/*blooden
dc.subjectDNA/*immunologyen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectImmunoglobulin Isotypes/classificationen
dc.subjectInterleukin-4/*blooden
dc.subjectLupus Erythematosus, Systemic/blood/*immunologyen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.titleRelationship of interleukin-4 to isotypic distribution of anti-double-stranded DNA antibodies in systemic lupus erythematosusen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/8353462-
heal.identifier.secondaryhttp://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000236484-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1993-
heal.abstractIgG subclasses of anti-double-stranded DNA antibodies were determined in 182 patients with systemic lupus erythematosus. All isotypes were detected, but IgG1 and IgG3 were predominant (62 and 51% of the cases, respectively). An average of 64 +/- 27% was IgG1, 16 +/- 22% IgG2, 16 +/- 19% IgG3 and 4 +/- 10% IgG4. The rank order or frequency was IgG1, IgG3, IgG2 and IgG4 in patients with musculoskeletal involvement; IgG1, IgG2, IgG3 and IgG4 in those with renal complications; IgG3, IgG1, IgG2 and IgG4 in those with cutaneous involvement; and IgG1, IgG3, IgG2 and IgG4 in those with hematological manifestations. Interleukin-4 (IL-4) was detectable in 17 of 36 selected patients, as opposed to 1 of 40 normal controls. The percentage of the total autoantibody contributed by IgG1 was significantly higher (p < 0.03) in these patients than in the remainder with undetectable levels of IL-4.en
heal.journalNameInt Arch Allergy Immunolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons